Singh Shawn bought VTGN
June 30, 2026 · Form 4 insider transaction
Singh Shawn bought 36,818 shares of Vistagen Therapeutics, Inc. at $0.19 per share, a transaction worth $7.1K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
36,818
Price
$0.19
Total value
$7.1K
InsiderSingh Shawn
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after54,846
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended (the "ESPP"), in a transaction exempt under Rule 16b-3 and Rule 16b-3(d). The Reporting Person purchased the maximum amount permitted under the ESPP.